Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarco... von Mita, M.M., Poplin, E., Britten, C.D., Tap, W.D., Rubin, E.H., Scott, B.B., Berk, L., Rivera, V.M., Loewy, J.W., Dodion, P., Haluska, F., Sarantopoulos, J., Mita, A., Tolcher, A.

Volltext

Phase I and dose ranging, phase II studies with IPH2201, a humanized monoclonal antibody targeting HLA-E receptor CD94/NKG2A von Seymour, L., Tinker, A., Hirte, H., Wagtmann, N., Dodion, P.

Volltext

Ridaforolimus (AP23573; MK-8669) in Combination with Trastuzumab for Patients with HER2-Positive Trastuzumab-Refractory Metastatic Breast Cancer: A Multicenter Phase 2 Clinical Tri... von Yardley, D., Seiler, M., Ray-Coquard, I., Melichar, B., Hart, L., Dieras, V., Barve, M., Melnyk, A., Dorer, D., Turner, C., Dodion, P.

Volltext

Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following cli... von Chawla, S. P., Blay, J., Ray-Coquard, I. L., Le Cesne, A., Staddon, A. P., Milhem, M. M., Penel, N., Riedel, R. F., Bui Nguyen, B., Cranmer, L. D., Reichardt, P., Bompas, E., Song, Y., Lee, R., Eid, J. E., Loewy, J., Haluska, F. G., Dodion, P. F., Demetri, G. D.

Volltext

Intraperitoneal Chemotherapy With Cisplatin and Melphalan von Piccart, Martine J., Abrams, Jeffrey, Dodion, Pierre F., Crespeigne, Nadine, Sculier, Jean Paul, Pector, Jean Claude, Finet, Claude, Nouwijnck, Claire, Bondue, Henri, Atassi, Ghanem, Kenis, Yvon

Volltext

Dose‐ranging, placebo‐controlled study of cetirizine nasal spray in adults with perennial allergic rhinitis von Clement, P., Roovers, M. H. W., Francillon, C., Dodion, P.

Volltext

Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer von Vermorken, J. B., Gundersen, S., Clavel, M., Smyth, J. F., Dodion, P., Renard, J., Kaye, S. B.

Volltext

Chemotherapy in the elderly von Dodion, P.

Volltext

Clinical pharmacology in oncology. Recent advances von Dodion, P.

Volltext

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck von Clavel, M., Cognetti, F., Dodion, P., Wildiers, J., Rosso, R., Rossi, A., Gignoux, B., Van Rymenant, M., Cortes‐Funes, H., Dalesio, O., Kirkpatrick, A., Rozencweig, M.

Volltext

Phase I study of intravenous menogaril administered intermittently von Dodion, P, Sessa, C, Joss, R, Crespeigne, N, Willems, Y, Kitt, M, Abrams, J, Finet, C, Brewer, J E, Adams, W J

Volltext

P105 Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer von Davidson, N., Neven, P., Llombart, A., Bundred, N., Monnier, A., DeBoer, R., Giardina, G., Editmann, H., Schenk, N., Dodion, P.

Volltext

Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma von KAYE, S. B, DODION, P, CAVALLI, F, CLAVEL, M, MONFARDINI, S, BOKKEL-HUININK, W, WAGENER, D. T, GUNDERSEN, S, STOTER, G, SMITH, J, RENARD, J, VAN GLABBEKE, M

Volltext

Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex von Dodion, P F, de Valeriola, D, Crespeigne, N, Kantrowitz, J D, Piccart, M, Wery, F, Kerger, J, Egorin, M J, Forrest, A, Bachur, N R

Volltext

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary von STAQUET, M, BROWN, B. W. JR, ROZENCWEIG, M, VAN MUYLDER, E, DODION, P, SANDERS, C

Volltext

Phase I Clinical Trial of Oral Menogaril Administered on Three Consecutive Days von Dodion, P., De Valeriola, D., Crespeigne, N., Peeters, B., Wery, F., Van Berchem, C., Joggi, J., Kenis, Y.

Volltext

Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin) von Dodion, P, Davis, T A, Rozencweig, M, Crespeigne, N, Kenis, Y, Bachur, N R

Volltext

Clinical and pharmacokinetic phase I trial with the diethylaminoester of flavone acetic acid (LM985, NSC 293015) von Dodion, Pierre F., Abrams, Jeffrey, Gérard, Béatrice, Crespeigne, Nadine, Peeters, Bernadette, Van Berchem, Christine, Kenis, Yvon

Volltext

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells In vitro von Dodion, P., Sanders, C., Rombaut, W., Mattelaer, M.A., Rozencweig, M., Stryckmans, P., Kenis, Y.

Volltext

In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015) von Schroyens, Wilfried A., Dodion, Pierre F., Sanders, Charlotte, Loos, Micheline, Dethier, Nathalie E., Delforge, Alain R., Stryckmans, Pierre A., Kenis, Yvon

Volltext